Bioventus (BVS) Cash from Operations (2020 - 2026)
Bioventus filings provide 6 years of Cash from Operations readings, the most recent being 37968000.0 for Q4 2025.
- On a quarterly basis, Cash from Operations rose 96.5% to 37968000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 74673000.0, a 92.48% increase, with the full-year FY2025 number at 74673000.0, up 92.48% from a year prior.
- Cash from Operations hit 37968000.0 in Q4 2025 for Bioventus, up from 30098000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 37968000.0 in Q4 2025 to a low of 21019000.0 in Q2 2022.
- Median Cash from Operations over the past 5 years was 9260500.0 (2023), compared with a mean of 6913300.0.
- Biggest five-year swings in Cash from Operations: plummeted 776.75% in 2023 and later skyrocketed 267.85% in 2024.
- Bioventus' Cash from Operations stood at 13117000.0 in 2021, then crashed by 60.02% to 5244000.0 in 2022, then skyrocketed by 56.46% to 8205000.0 in 2023, then soared by 135.49% to 19322000.0 in 2024, then surged by 96.5% to 37968000.0 in 2025.
- The last three reported values for Cash from Operations were 37968000.0 (Q4 2025), 30098000.0 (Q3 2025), and 25938000.0 (Q2 2025) per Business Quant data.